Credit: Shutterstock. Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types. Treatment with denosumab (Prolia ®) was associated with ...

Vancouver, British Columbia — A highly controlled retrospective analysis suggests that denosumab (Prolia) leads to greater reduction in fracture risk than does zoledronic acid (Reclast) among ...

Ultrasound-guided axillary nerve block (ANB) was as effective as fracture hematoma block (FHB) in providing pain control for forearm fracture reduction in emergency departments (EDs), with ANB causing ...

Ultragenyx and Mereo BioPharma have broken off another piece of brittle bone data, linking their drug candidate to sustained reductions in fracture rates in a midphase clinical trial. The results come ...

Please provide your email address to receive an email when new articles are posted on . Vitamin D3 supplementation did not reduce fracture risk in a large cohort of U.S. adults not selected for ...

LONDON--(BUSINESS WIRE)--FOR MEDICAL BUSINESS/INDUSTRY TRADE MEDIA ONLY A real world evidence study, presented at the 13 th International Conference on Osteoporosis, Arthritis and Musculoskeletal ...

--Amgen today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia ® injection reduced fracture ...

With increasing life expectancy, frailty and hip fractures will correspondingly increase in numbers, now at more than 300,000 fractures per year and projected to rise to more than 500,000 by 2040. Hip ...

A peer-reviewed study of more than 46,000 older adults with type 2 diabetes found that patients who started GLP-1 receptor agonist drugs faced an 11 percent higher risk of fragility fractures compared ...